I-MAB Stock (NASDAQ: IMAB) stock price, news, charts, stock research, profile.
Open | $1.63 |
Close | $1.63 |
Volume / Avg. | 375.25K / 215.28K |
Day Range | 1.55 - 1.64 |
52 Wk Range | 1.16 - 3.17 |
Market Cap | $135.88M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 3.29% |
Days to Cover | 9.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of I-MAB (NASDAQ:IMAB) through any online brokerage.
Other companies in I-MAB’s space includes: Galectin Therapeutics (NASDAQ:GALT), Tevogen Bio Holdings (NASDAQ:TVGN), aTyr Pharma (NASDAQ:ATYR), RAPT Therapeutics (NASDAQ:RAPT) and Adagene (NASDAQ:ADAG).
There is no analysis for I-MAB.
I-MAB has a consensus price target of $12.25.
The stock price for I-MAB (NASDAQ: IMAB) is $1.68 last updated July 15, 2024 at 9:03 AM EDT.
There are no upcoming dividends for I-MAB.
I-MAB’s H1 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for I-MAB.
I-MAB is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.